Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSUZET-AMI: Low-dose Rosuvastatin + Ezetimibe vs High-dose Rosuvastatin in AMI
NCT04499859Phase 4Recruiting
- Start
- Oct 2020
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, rosuvastatin in myocardial infarction (MI). Started Oct 2020; status: recruiting.
02
Drugs
ezetimiberosuvastatin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04499859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04499859.